Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2012-02-29
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Little is know about the immediate effects of chocolate consumption, or the differences between milk and dark chocolate with regards to these effects. The project will investigate the effect of a single bar of dark or milk chocolate upon blood flow to the brain, using simple ultrasound tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Flavanol-Rich Cocoa and Cerebral Blood Flow
NCT00825695
Comparison of Pure Epicatechin and Cocoa on Markers of Vascular Function
NCT02221791
The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males
NCT02789761
Effects of Dark Chocolate on the Risk Factors of Cardiovascular Diseases
NCT06808282
Can Cocoa Flavanols Protect Endothelial Function During Prolonged Sitting in Healthy Older Adults?
NCT07265869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
100 g containing 70% or 34% cocoa
Healthy controls
cocoa
70% versus 34%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cocoa
70% versus 34%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
Exclusion Criteria
* Any known cardiovascular disease, diabetes, throid disease, high blood pressure, hyperlipidaemia or pregnancy
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven Burke
Sponsor's representative
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western Infirmary
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN11MT497
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.